Department of Medicine, University of Verona, Verona 37124, Italy.
Department of Clinical Sciences, Clinical Research Center, Lund University, Malmö 21428, Sweden.
J Clin Endocrinol Metab. 2022 Nov 23;107(11):3080-3085. doi: 10.1210/clinem/dgac501.
Vitamin D (Vit-D), parathyroid hormone (PTH), and fibroblast growth factor 23 (FGF23) are the major calciotropic hormones involved in the regulation of blood calcium levels from the intestine, kidney, and bone through a tight endocrine feedback loop system. Altered levels of calcium itself or through the effect of its regulatory hormones could affect blood pressure (BP), but the exact mechanisms remain unclear.
To evaluate whether a causal relationship exists between serum calcium level and/or the regulatory hormones involved in its homeostasis with BP, we performed a two-sample Mendelian randomization (MR) study.
From 4 large genome-wide association studies (GWAS) we obtained independent (r2 < 0.001) single nucleotide polymorphisms (SNPs) associated with serum calcium (119 SNPs), Vit-D (78 SNPs), PTH (5 SNPs), and FGF23 (5 SNPs), to investigate through MR their association with systolic BP (SBP) and diastolic BP (DBP) in a Swedish urban-based study, the Malmö Diet and Cancer study (n = 29 298). Causality was evaluated by the inverse variance weighted method (IVW) and weighted median, while MR Egger and MR-PRESSO were used as sensitivity analyses.
Genetically predicted serum calcium level was found to be associated with DBP (IVW: beta = 0.10, SE = 0.04, P = 0.007) and SBP (IVW: beta = 0.07, SE = 0.04, P = 0.04). Genetically predicted Vit-D and PTH showed no association with the traits, while FGF23 was inversely associated with SBP (IVW: beta = -0.11, SE = 0.04, P = 0.01), although this association lost statistical significance in sensitivity analysis.
Our study shows a direct association between genetically predicted calcium level and DBP, and a weaker association with SBP. No such clear association was found for genetically predicted calciotropic hormone levels. It is of interest to detect which target genes involved in calcium homeostasis mediate the effect of calcium on BP, particularly for improving personalized intervention strategies.
维生素 D(Vit-D)、甲状旁腺激素(PTH)和成纤维细胞生长因子 23(FGF23)是调节血液中钙水平的主要钙调节激素,通过一个紧密的内分泌反馈环路系统,从肠道、肾脏和骨骼中进行调节。钙本身水平的变化或其调节激素的作用可能会影响血压(BP),但确切的机制尚不清楚。
为了评估血清钙水平及其与钙稳态相关的调节激素与血压之间是否存在因果关系,我们进行了一项两样本 Mendelian 随机化(MR)研究。
我们从 4 项大型全基因组关联研究(GWAS)中获得了与血清钙(119 个 SNP)、Vit-D(78 个 SNP)、PTH(5 个 SNP)和 FGF23(5 个 SNP)相关的独立(r2 < 0.001)单核苷酸多态性(SNP),并通过 MR 分析来研究它们在斯德哥尔摩市基于人群的马尔默饮食与癌症研究(n = 29298)中与收缩压(SBP)和舒张压(DBP)的相关性。通过逆方差加权法(IVW)和加权中位数评估因果关系,同时还使用 MR Egger 和 MR-PRESSO 作为敏感性分析。
遗传预测的血清钙水平与 DBP 相关(IVW:beta = 0.10,SE = 0.04,P = 0.007)和 SBP 相关(IVW:beta = 0.07,SE = 0.04,P = 0.04)。遗传预测的 Vit-D 和 PTH 与这些特征无关联,而 FGF23 与 SBP 呈负相关(IVW:beta = -0.11,SE = 0.04,P = 0.01),尽管在敏感性分析中这种关联失去了统计学意义。
我们的研究表明,遗传预测的钙水平与 DBP 呈直接相关,与 SBP 呈较弱相关。而遗传预测的钙调节激素水平则没有明显的关联。检测参与钙稳态的靶基因如何介导钙对 BP 的影响是很有意义的,特别是对改善个性化干预策略。